Real-world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years
| Image |  |
|---|---|
| Description | scientific article published on 04 October 2020 |
| Author/s |
author: Michael Wang Amy D Shapiro Miguel Escobar |
| Publication date | October 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |